scispace - formally typeset
A

Ann M. Bode

Researcher at University of Minnesota

Publications -  449
Citations -  22510

Ann M. Bode is an academic researcher from University of Minnesota. The author has contributed to research in topics: Kinase & Signal transduction. The author has an hindex of 73, co-authored 441 publications receiving 19562 citations. Previous affiliations of Ann M. Bode include University of Oregon & Seoul National University.

Papers
More filters
Journal ArticleDOI

Post-translational modification of p53 in tumorigenesis

TL;DR: A thorough understanding of p53 will be extremely useful in the development of new strategies for treating and preventing cancer, including restoration of p 53 function and selective killing of tumours with mutant TP53.
Journal ArticleDOI

Biology of free radical scavengers: an evaluation of ascorbate.

TL;DR: Ascorbic acid is discussed in detail, and an analysis is made of whether it has the properties mentioned, and several water‐soluble candidates are mentioned, with most having no more than one or two of the attributes listed.
Journal ArticleDOI

AKt as a therapeutic target for cancer

TL;DR: The abnormal overexpression or activation of AKT has been observed in many cancers, including ovarian, lung, and pancreatic cancers, and is associated with increased cancer cell proliferation and survival, so targeting AKT could provide an important approach for cancer prevention and therapy.
Journal Article

Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase.

TL;DR: It is found that in a mouse JB6 epidermal cell line, resveratrol activated extracellular-signal-regulated protein kinases (ERKs), c-Jun NH2-terminal kinases, and p38 kinase and induced serine 15 phosphorylation of p53.
Journal ArticleDOI

Molecular targets of phytochemicals for cancer prevention

TL;DR: Dietary phytochemicals, thought to be safe for human use, have emerged as modulators of key cellular signalling pathways, and the task now is to understand how these chemicals perturb these pathways by modelling their interactions with their target proteins.